Last reviewed · How we verify
BLU-U Blue Light Photodynamic Therapy — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
BLU-U Blue Light Photodynamic Therapy (BLU-U Blue Light Photodynamic Therapy) — Medical Dermatology Specialists.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| BLU-U Blue Light Photodynamic Therapy TARGET | BLU-U Blue Light Photodynamic Therapy | Medical Dermatology Specialists | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- BLU-U Blue Light Photodynamic Therapy CI watch — RSS
- BLU-U Blue Light Photodynamic Therapy CI watch — Atom
- BLU-U Blue Light Photodynamic Therapy CI watch — JSON
- BLU-U Blue Light Photodynamic Therapy alone — RSS
Cite this brief
Drug Landscape (2026). BLU-U Blue Light Photodynamic Therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/blu-u-blue-light-photodynamic-therapy. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab